The global cardiovascular needles market is driven by increase in demand for cardiovascular needles due to rising number of cardiovascular interventions across the globe. Cardiovascular needles are used during a number of cardiovascular surgeries such as open heart surgery, cardiac valve procedures, heart transplant, etc. The factors that propel the growth of the global cardiovascular needle market include rising geriatric population and rising occurrence of cardiovascular diseases. There are also other factors that fuel the growth of the market such as excessive intake of tobacco, high number of smoking population, obesity, increasing co-morbidities, and changing standard of living.
On the other hand, there are also factors that hamper the growth of the market such as increasing usage of surgical staples rather than needles. The global cardiovascular needle market is classified on the basis of product type, usage, applications, end use, and geography. On the basis of product type, the global market is classified into two major types: round bodied needles and cutting needles. Round bodied needles consist of taper point needles and blunt point needles. The cutting needles consist of conventional cutting needles and reverse cutting needles.
On the basis of usage, the global cardiovascular needle market is classified as single use or eyeless needles and multiple use or eyed needles. Among the usage, single use needles segment projected to have a greater share owing to growing number of outpatient procedures as well as growing awareness about infectious diseases. On the basis of applications, the global market is classified as open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.
On the basis of end user, the global cardiovascular needle market is classified as hospitals and ambulatory surgical centers. Among the end user, hospital segment is estimated to account a major share owing to rising number of persistent cardiovascular interventions. On the basis of geography, the global market is classified as North America, Latin America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan, Japan, and Middle East & Africa.
The North American region comprises the U.S. and Canada. Latin America comprises Mexico and Brazil. The Western European region comprises Germany, Italy, France, England, Spain, Nordic countries, and BENELUX. The Eastern European region comprises Poland, Russia and Rest of Eastern Europe. Asia Pacific region comprises China, India, ASEAN, and Australia & New Zealand. The Middle East and Africa region comprises GCC, South Africa, North Africa, and Rest of MEA.
In case of geographical region, the North American region dominates a major share of the global cardiovascular needle market over the forecast due to the increasing geriatric population, advanced healthcare facility, and increased life expectancy. Moreover, the introduction of the latest technology such as laser drilled cardiovascular needle is projected to fuel the demand for the market over the forecast period.
The North America market is followed by Europe as well as Asia Pacific. Europe and Asia Pacific equally hold the second largest position in the global cardiovascular needle market. Some of the prominent players that fuel the growth of the global market include Barber of Sheffield Ltd., CP Medical, Inc., Ethicon US, LLC, MANI, Inc., FSSB surgical needles GmbH SMB Corporation, Quality Needles Pvt. Ltd., etc.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.